Innate Pharma SA
Last · NASDAQ$1.43-0.04 (-2.72%)close · yahoo · 13h ago
Vol 9.3K ≈ 13.3K
MA10MA20MA50
Market cap$159.73M111.7M sh
P/E · TTM-2.4fwd -3.0 · eps -0.59 · loss
Beta1.19vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.17$2.71
Volume9.3Ksession
Issuer
Legal nameInnate Pharma SA
HQUnited States (US)
ListingUS IPHA
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001598599
CIK0001598599
Websitewww.innate-pharma.com
Loading chart…
Upcoming earnings
THU.5NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
2.3M
Earnings transcripts
- Motley Fool
Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript
Innate Pharma SA
- Issuer webcast
Q2 2026 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q1 2026 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q3 2025 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q2 2025 earnings call transcript
Innate Pharma SA
- Issuer webcast
Q1 2025 earnings call transcript
Innate Pharma SA
Documents
FormReporting forFiledFlags
Showing 5 of 111 filings